For each of the following patients, select the most appropriate targeted antimicrobial therapy based on current clinical guidelines and stewardship principles.
- A 25-year-old non-pregnant man presents with an expanding, annular erythematous rash with central clearing after a hiking trip.Oral doxycycline
- A 28-year-old woman in her first trimester of pregnancy presents with an isolated erythema migrans rash.Oral amoxicillin
- A 35-year-old man presents with purulent urethral discharge; nucleic acid amplification testing is positive for Neisseria gonorrhoeae and negative for Chlamydia trachomatis.Intramuscular ceftriaxone monotherapy
- A 19-year-old with active infectious mononucleosis requires treatment for a confirmed concurrent Group A streptococcal pharyngitis.Oral penicillin V
Answer
The non-pregnant patient with Lyme receives oral doxycycline. The pregnant patient with Lyme receives oral amoxicillin. The patient with isolated gonorrhea receives intramuscular ceftriaxone monotherapy. The patient with EBV and streptococcal pharyngitis receives oral penicillin V.
Each specific clinical scenario requires a nuanced selection of antibiotics. Non-pregnant patients with early Lyme disease receive doxycycline. Pregnant patients with early Lyme must avoid tetracyclines and receive amoxicillin instead. Uncomplicated, isolated gonococcal infection is now treated with ceftriaxone alone to promote antibiotic stewardship (sparing azithromycin). Finally, treating streptococcal pharyngitis in a patient with infectious mononucleosis requires penicillin V to avoid the characteristic aminopenicillin-induced rash.
Step-by-Step Solution
Key Concept
First-line antimicrobial selection and stewardship in common infectious diseases
Estimated Time:1m 0s